| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/22/2009 | US20090022713 Anti-pro87299 antibodies |
| 01/22/2009 | US20090022710 Nuclear factor of activated t cells receptor |
| 01/22/2009 | US20090022659 Antibodies to TNF alpha and use thereof |
| 01/22/2009 | US20090022657 Novel CXCL8 antagonists |
| 01/22/2009 | DE102007032832A1 Fermenting sunchoke, useful e.g. to reduce blood pressure, comprises crushing the sunchoke, mixing mash with microorganisms, providing a cask, pressing mash to juice, filling the juice into a cask, storing, removing and cleaning the juice |
| 01/22/2009 | CA2729011A1 Varicella zoster virus-virus like particles (vlps) and antigens |
| 01/22/2009 | CA2693956A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2693590A1 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | CA2693137A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/21/2009 | EP2017343A2 Protein A based binding domains with desirable activities |
| 01/21/2009 | EP2017342A1 Recombinant allergen with reduced enzymatic activity |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017281A1 Toll-like receptor 9 agonists |
| 01/21/2009 | EP2017269A2 A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof |
| 01/21/2009 | EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2017257A1 2-aminobutanol compound and use thereof for medical purposes |
| 01/21/2009 | EP2016945A1 Pharmaceutical containing thiazole derivative as active ingredient |
| 01/21/2009 | EP2015771A1 Modulation of t helper cell-mediated immune responses |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | EP1127107B1 Methods for the production of tcr gamma delta t cells |
| 01/21/2009 | EP1053021B1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
| 01/21/2009 | CN101351554A Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 01/21/2009 | CN101351477A Anti-CD19 antibodies with reduced immunogenicity |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101348812A Lichenin, and preparation and use thereof |
| 01/21/2009 | CN101348527A Production and powdering process of sodium carboxymethylstarch, and use thereof |
| 01/21/2009 | CN101348516A Refining process of triamcinolone acetonide raw medicine |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347618A Medicament composition for treating respiratory disease |
| 01/21/2009 | CN101347466A Capsules containing Ganoderma lucidum and ostrich bones as well as organs |
| 01/21/2009 | CN101347457A Indirect type immunological tolerance revulsion |
| 01/21/2009 | CN101347446A Medicament composition containing astragalus polysaccharide and ginseng bud saponin and uses thereof |
| 01/21/2009 | CN101347436A Uses of methylprednisolone and derivatives thereof in preparing medicament for treating allergic rhinitis |
| 01/21/2009 | CN101347424A Use of luteolin in preparing anticomplement medicament |
| 01/21/2009 | CN101347418A Use of 8-0-4í»type lignan in preparing anticomplement medicament |
| 01/21/2009 | CN101347408A Kukoline intravenous transfusion preparation |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453091C Capsule of purple sweet potato, its production and application |
| 01/21/2009 | CN100453080C Lindera root alkaloid, its preparation method and application in medicine preparation |
| 01/21/2009 | CN100452980C Lily bulb tea and manufacturing method thereof |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479503 Such as multiple sclerosis; also inactivating HIV virus via extracorporeal treatment of blood; use of a green porphyrin or porfimer sodium |
| 01/20/2009 | US7479486 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids |
| 01/20/2009 | US7479285 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | US7479266 Polyvalent conjugate vaccine for cancer |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2465871C Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2391239C Benzopyran derivative and antiallergic agent |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2279935C Chelating immunostimulating complexes |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/20/2009 | CA2247103C Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
| 01/15/2009 | WO2009007298A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 01/15/2009 | WO2009006899A1 Compressed chewing gum tablet comprising taste-masking agent |
| 01/15/2009 | WO2009006668A1 Modulators of antigen-dependent t cell proliferation |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008140251A3 Cyclooxygenase-2 inhibitors |
| 01/15/2009 | WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 01/15/2009 | WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 01/15/2009 | WO2008009426A9 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018158 Crystal forms of an imidazole derivative |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018113 Novel Cylopenta[B]Benzofuran Derivatives and the Utilization Thereof |
| 01/15/2009 | US20090018105 Means and Methods for the Treatment and Prevention of Allergic Diseases |
| 01/15/2009 | US20090018093 Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics |
| 01/15/2009 | US20090018086 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus |
| 01/15/2009 | US20090018081 Activatable clostridial toxins |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018067 Regulatory t cell epitopes, compositions and uses thereof |
| 01/15/2009 | US20090017145 Tri ascorbate formulation |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017074 Culture medium for haemophilus influenzae type b |
| 01/15/2009 | US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 01/15/2009 | US20090017061 Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan |
| 01/15/2009 | US20090017060 Cleavable Vaccine Compositions and Uses Thereof and Methods of Making and Using the Same |
| 01/15/2009 | US20090017059 Complex of serotype to bacteria toxin such as tetanus, diphtheria, pertussis, cytolysin |
| 01/15/2009 | US20090017057 Stimulation of an immune response by cationic lipids |
| 01/15/2009 | US20090017051 Allergy vaccines and their preparation |